Showing posts with label pneumonia. Show all posts
Showing posts with label pneumonia. Show all posts

Monday, January 14, 2008

Eminem Is Recovering From Pneumonia

Eminem is recovering from a bout with pneumonia that sent him to the hospital. "Over the holidays, Marshall Mathers, aka Eminem, was under doctor's care at a Detroit-area hospital for complications due to pneumonia," the rapper's publicist, Dennis Dennehy, said Tuesday. "He has since been released and is doing well recovering at home."

Eminem's illness first was reported by celebrity Web site TMZ.com.

Eminem, 35, rose to stardom thanks to a number of best-selling CDs, personal lyrics and a starring role in the hit 2002 film "8 Mile."

He has won Grammys, including best rap album for "The Slim Shady LP," "The Marshall Mathers LP" and "The Eminem Show," as well as an Oscar for the song "Lose Yourself" from "8 Mile.Eminem appears at the MTV Video Music Awards in New York in this, Aug. 28, 2003, file photo. Eminem is recovering from a bout with pneumonia that sent him to the hospital. "Over the holidays, Marshall Mathers, aka Eminem, was under doctor's care at a Detroit-area hospital for complications due to pneumonia," the rapper's publicist, Dennis Dennehy, said Tuesday. "He has since been released and is doing well recovering at home." (AP Photo/Julie Jacobson, file)


Source:ap.google.com

It's unusual to meet someone happy to be on a waiting list

Jim Bair, the Keizer man awaiting a double-lung transplant, is keeping his regularly scheduled doctor's appointment today in Seattle. That might not sound noteworthy, until you hear about what he just went through.

He came down with pneumonia, was removed from the national transplant list, suffered a mild stroke, recovered from both ailments, and then returned to the waiting list.

The 50-year-old husband and father of two teenager boys is breathing a sigh of relief, as much as he's able.

His lungs are working at about 18 percent capacity because of obliterative bronchiolitis, which is characterized by inflammation and scarring of the tiny airways. The disease eventually turns fatal without a transplant.

Bair, who believes his lungs are scarred from working years amid the toxic fumes at an agriculture seed-cleaning plant, has been on the list since Oct. 3. The average wait time at the University of Washington Medical Center, where he will have the transplant, is about four months.

He's eager for his monthly checkup today with the transplant team. Just a few days ago, he had doubts that he would be able to keep the appointment, let alone get back on the waiting list.

"It's been really scary," Bair said. "Having the stroke was the scariest thing I've ever been through in my life. I actually shouldn't even be here."

Doctors had warned if he ever came down with pneumonia, he probably wouldn't survive. But here he is.

Jim and his wife, Lisa, have had their bags packed -- as recommended -- since he made the list. And for three months, their lives have been in agonizing limbo.

"It's the waiting and living out of a suitcase and every time the phone rings thinking, 'Is it the call?' That part of it is very stressful," Lisa Bair said.

The Bairs have been told that Jim has only one person on the transplant list ahead of him with his blood type. They've known that since before Christmas, and were devastated when a mild stuffy nose to start the New Year turned quickly into pneumonia.

Jim wasn't well enough to stay on the transplant list, and they knew it.

"You don't want to have to make that phone call and tell them he's sick," Lisa said. "But you have to."

Jim naturally was depressed. It helped to learn that he could go back on the list, in exactly the same spot, if the pneumonia cleared.

He was taking antibiotics and on the mend when he was dealt another blow Jan. 5. He called his wife at work to tell her he thought the right side of his face was sagging. She hurried home and called 911. He had suffered a mild stroke. But by the next day, the right side of Jim's face was back to normal and he was feeling much better. Just three days after the stroke, he was back on the list. Lisa believes he was able to bounce back so quickly because he had lost 80 pounds to prepare for the transplant and had been walking two to three miles a day.

The Bairs will discuss with doctors today the possibility of relocating soon to Seattle, something they'll have to do eventually. Once Jim has the transplant and leaves the hospital, he needs to be nearby for up to three months.

Friends and family continue to raise money for the Bairs, who had to sell their Keizer home when they became a one-income family. Jim has been unable to work since May 2006, and Lisa is a hair stylist. They have insurance, but it doesn't cover all medical expenses.

Source:www.statesmanjournal.com

Doctors caring for Indonesia's former dictator Suharto said Monday he had contracted pneumonia in one of his lungs — one of the most dangerous threats

The doctors said they were amazed that Suharto was still clinging to life after their weekend prognosis that he had only a slim chance of recovering from multiple organ failure. Family members, meanwhile, said they would leave it to physicians to decide if and when the 86-year-old should be taken off life support.

Pulmonologist Hadiarto Mangunnegoro said one of Suharto's lungs had become infected with mild pneumonia — one of the gravest threats to patients suffering from organ failure. Doctors were trying to make sure it did not spread to the second lung, he said, which "would be very dangerous."

Hospital visitation rights had been strictly limited, Mangunnegoro said.

But while Suharto's lungs and kidneys were barely functioning, the condition of his heart appeared to be improving Monday, and he was conscious and able to respond when asked to take someone's hand, said Marjo Subiandono, the chief presidential doctor.

"We are quite amazed at how strong he is ... maybe because he is a former soldier, a general," Subiandono told reporters. "If I was in the same state, I don't think I would have made it this far."Suharto, whose 32-year regime was widely regarded as one of the 20th century's most brutal and corrupt, was rushed to the hospital on Jan. 4 with anemia and a dangerously low heart rate.

He initially responded well to a blood transfusion and dialysis treatment, but his condition has fluctuated almost daily since then. Aides said privately he had been on the verge of death at least twice, but fought back.

Suharto was ousted one decade ago amid massive student protests and nationwide riots, opening the way for democracy in this predominantly Muslim nation of 235 million people. He withdrew from public life, venturing from his comfortable villa in the capital, Jakarta, only to attend family functions or for medical emergencies.

He has been accused of overseeing a purge of more than half a million leftist opponents soon after seizing power in a 1965 coup. Hundreds of thousands more were killed or imprisoned in the decades that followed — crimes for which no one has ever been punished.

Transparency International, an anti-corruption watchdog, has said Suharto and his family amassed billions of dollars in state funds, an allegation he has denied.

A series of strokes in recent years have left Suharto with permanent brain damage and impaired speech, keeping him from facing trial.

Over the past week a steady stream of high-profile visitors have come to visit the former strongman, including Malayisa's former Prime Minister Mahathir Mohamad on Monday and Singapore's former Prime Minister Lee Kuan Yew on Sunday, two old friends who like Suharto oversaw decades of rapid economic growth at the expense of democratic freedom in their neighboring countries.

Indonesian President Susilo Bambang Yudhoyono, Cabinet ministers and ruling party leaders, many of whom held positions in the government during Suharto's reign, also have flocked to Suharto's bedside in recent days — a sign of his continuing influence over the ruling elite.

"As a human being, like other leaders, certainly he made mistakes and committed wrongdoing, but it would not hurt us to thank him and appreciate his achievements and services to the country," Yudhoyono said over the weekend.

Source:ww.foxnews.com

Docs: Home Care OK for Kids' Pneumonia

Children with severe pneumonia can be treated just as effectively at home as in a hospital, according to new research. Doctors in Pakistan found that children taking antibiotics at home were as likely to survive serious pneumonia as those treated in hospitals. The study was published Friday in the British medical journal, The Lancet.

"If this (home) treatment was implemented on a wide scale, then we could potentially save millions of children," said Dr. Renee Van de Weerdt, a child health expert at UNICEF, who was not involved in the study.

"This shows us that we can do something about pneumonia at the community level," Van de Weerdt said. "It doesn't always require a sophisticated hospital."

Pneumonia is the top killer of children under five worldwide, causing one-fifth of the 10 million deaths every year.

Pneumonia is an inflammation of the lungs that causes coughing, breathing difficulties, fever and muscle pain. About five to 10 percent of all children under five in developing countries get pneumonia every year. Children with HIV or malaria are at particular risk.

Under current World Health Organization guidelines, health workers refer children with severe pneumonia to hospitals to receive antibiotics through injections. But in many poor countries, children referred to hospitals often don't receive care if their parents cannot afford it or if there is no nearby hospital.

In the Lancet study, doctors in Pakistan randomly assigned children with serious pneumonia to either receive antibiotic shots in the hospital for two days, or to take antibiotics at home for five days. Parents of the children sent home were instructed how and when to give their children the antibiotics.

The research was conducted at seven sites across Pakistan: 1,012 children were hospitalized and 1,025 were treated at home. The children were aged between about three months and five years old.

Among the hospitalized children, 87 children did not respond to the treatment or developed complications. That compared to 77 children in those treated at home. Five children died during the study; four were in the hospitalized group and one was at home.

The study was conducted by researchers at Boston University's School of Public Health and colleagues, and was paid for by WHO and the U.S. Agency for International Development.

Treating children with severe pneumonia at home would also save health systems thousands of dollars. A course of medicines to be taken at home costs $2 at most.

Based on the Pakistani results and those of previous studies, WHO said it would soon revise its guidelines for children with pneumonia.

UNICEF said that trained community health workers, rather than parents, should be the ones giving drugs to children at home with severe pneumonia. "At the implementation level, there are quality control challenges," Van de Weert said. "We don't want antibiotics to be used wildly by anyone."

WHO said that not all children with severe pneumonia could be treated at home, and that a small percentage would still require hospitalization.

"Pneumonia is the single biggest killer of children in the world," said Dr. Shamim Qazi, a pediatrician at WHO. "We are hopeful that with the results from this study, we may be able to change that."

Source:ap.google.com

Small children are particularly susceptible to pneumonia

A cold can sometimes lead to pneumonia in infants, the Munich-based professional association of paediatricians said. Certain viruses can cause serious obstructive bronchitis or pneumonia, said Ulrich Fegeler, a spokesman for the association. Breathing becomes especially difficult and requires a lot of effort. Children with such illnesses typically can be treated only in a hospital.

Even children who are not as critically ill often need inhalation therapy that includes medicines for opening the respiratory passages and reducing swelling, the association said. Breathing is so exhausting that the babies cannot be nursed. Their bodies lose fluids due to fever. Parents therefore must ensure their children get enough to drink.

In less serious cases, drops to reduce swelling of the nasal passages are helpful as is propping up the upper body in bed. The room also should be well ventilated and not too warm.

The contagion spreads through the air or is passed from person to person on dirty objects or on the hands. Only careful hygiene and avoiding people with colds can help reduce the risk of getting sick, said the association. Parents should consult a doctor if their children have a persistent cough.

"Young children should not be given medicine to loosen phlegm or nasal drops without a doctor's advice," said Fegeler.

When cough relief medicines, which are popular among parents, but viewed skeptically by paediatricians, are taken in combination with cough suppressants, it can lead to a dangerous backup of secretions.

"And some nasal drops can affect the circulation or damage the mucous membrane inside the nose," Fegeler warned.

Source:www.earthtimes.org

Tuesday, July 10, 2007

A Critical Ally In Asia's Effort To Reduce Child Deaths

A new study from Bangladesh published online today in The Pediatric Infectious Disease Journal shows that routinely vaccinating infants against H. influenzae type b (Hib), a bacterium that causes deadly Hib pneumonia and meningitis, could save hundreds of thousands of children in Asia. Results showed that routine immunization of infants with a Hib conjugate vaccine prevented over one-third of life-threatening pneumonia cases and approximately 90% of Hib meningitis cases. A similar impact would be expected in other parts of the region.
Although countries in Asia with high mortality rates have long known that pneumonia and meningitis are a significant concern, many assumed that Hib was not a major cause. This vaccine study builds the evidence of the real burden of Hib pneumonia and meningitis as has been shown in other studies in Chile and Indonesia, that is that the proportion of pneumonia and meningitis prevented by the Hib conjugate vaccine is significantly higher than what can be detected through routine surveillance.

"There has been an ongoing disagreement about the total burden of Hib pneumonia and meningitis in Asia, but our findings provide evidence challenging the commonly held notion that these diseases are rare in Asia," said Dr Abdullah Baqui, Associate Professor, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA. "Our research shows that routine Hib vaccination is a feasible and highly effective way of preventing death related to Hib pneumonia and meningitis and could save the lives of a significant number of Asian children who die under the age of five."

"Bangladesh views Hib vaccine as an integral tool in our mission to improve child survival in Bangladesh," said Dr. Md. Abdul Quader Mian, Deputy Director EPI and Programme Manager Child Health & LCC, Ministry of Health, Bangladesh. "This study supported the conclusions of the consultative workshop organized in June 2006 by WHO around the introduction of the Hib vaccine into Bangladesh."

The study was conducted by researchers from International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B), Dhaka Shishu Hospital and John Hopkins University. The vaccine used in the study replaced the routine diphtheria, tetanus and pertussis (DTP) vaccine with a DTP-Hib combination. The combination vaccine did not require additional injections or visits to benefit from the expanded protection. Bangladesh recently applied for funding from the GAVI Alliance to introduce a DTP-Hepatitis B-Hib "pentavalent" combination which they hope to introduce into the routine childhood immunization program in 2008.

Despite a growing body of evidence, only 26% of the world's children live in countries with access to Hib vaccine. This means hundreds of thousands of children in Asian countries are currently not benefiting from this simple, life-saving vaccine. However, Bangladesh, Pakistan, Afghanistan, Sri Lanka and Bhutan have reviewed available evidence and made the decision to introduce Hib vaccine and applied for support from the GAVI Alliance.

"We are delighted that so many Asian countries are preparing to introduce the Hib vaccine and protect their children against Hib pneumonia and Hib meningitis" said Julian Lob-Levyt, Executive Secretary of the GAVI Alliance. "This is a clear indication of these governments' commitment to reduce child mortality."

The WHO recommends that all countries adopt Hib vaccine into routine child immunization programs. They estimate that Hib globally is responsible for 400,000 deaths each year in children under five years of age and around 3 million cases of serious illness resulting in long term consequences such as deafness, learning disabilities, paralysis and mental retardation.

"This simple, life-saving vaccine can prevent Hib pneumonia and meningitis in children, often called the 'invisible cause of forgotten child killers' in Asia," said Dr. Kent R. Hill, Assistant Administrator, Global Health. "Immunization programs, including Hib, are an essential component of USAID's strategy to prevent life-threatening childhood infections. These data are clear - Hib vaccine is an important addition to immunization programs through out Asia. Supply studies tell us quality manufacturers from developing countries are coming into the market very soon and prices for this vaccine will be coming down in the very near future. Now is the time for additional Asian countries to make this important addition to the EPI programs. I commend the GAVI Alliance and the countries of Bangladesh, Pakistan, Afghanistan, Sri Lanka and Bhutan for moving quickly to reduce needless Hib related child deaths."

source:www.sciencedaily.com

Medicare focus changes sought

Ninety-five percent of Medicare funding is being used to treat people after they become sick, say officials from the Centers for Medicare & Medicaid Services, while only one out of 10 Medicare beneficiaries access its full scope of preventative services.

“This needs to change,” said Jack Cheevers, communications director for the Southwest region of CMS. “If we don't take action now, costs associated with long-term disease and disability will balloon as baby boomers age.”

Medicare offers services aimed at combating chronic disease, including screenings for diabetes, cholesterol, colorectal cancer, breast cancer, cervical cancer, prostate cancer and glaucoma. Medicare also pays for flu and pneumonia shots, bone mass measurements for osteoporosis, smoking cessation counseling and training for diabetes self-management.

Yet less than 35 percent of beneficiaries have ever had a bone mass measurement. Only 33 percent of female beneficiaries had a Pap smear in the past year, and less than 59 percent have ever checked for colon cancer.

And although 200,000 Americans are hospitalized annually for flu or its complications, Cheevers said, less than 65 percent of Medicare beneficiaries got a flu shot in the past year - which are free under Medicare.

To combat the prevention gap, the U.S. Department of Health and Human Services is launching a nationwide campaign to inform seniors of available preventative health services. HHS will conduct a bus tour and will partner events in 48 states with a campaign that will reach California, Arizona and Nevada in late August.

“We need to make sure people understand the preventative services covered under Medicare because they're greatly expanded from what they used to be,” said Jeff Flick, regional administrator for CMS's Southwest region. “We need to tell the story about why these preventative benefits are so important, and what it can mean to the quality of life and the quality of health care.”

Flick said it's one thing to tell somebody that Medicare offers flu shots, but another thing to say there's almost 200,000 people hospitalized every year because of flu complications and another 36,000 that die from complications.

“We know that if people take the time to get a flu shot, to take the time to get their cardiovascular and diabetic screenings, that we can prevent these illnesses from happening,” Flick said. “When we do that, we're not only improving the health of these individuals. We're also saving taxpayer dollars.”

If more people used Medicare's preventative services, the health care provider's future might look brighter and health care costs might drop lower.

“It will put Medicare on a better financial footing for the future,” Flick said. “We have large numbers of baby boomers that will start coming into the Medicare program about three years from now, so anything we do for Medicare will become vitally important in the future.”

The Southwest region, which includes California, Arizona, Nevada and Hawaii, is in a unique position because it has more ethnic groups that don't always access preventative health services equally, Flick said.

Fifty-nine percent of whites have been vaccinated for pneumonia, for example, while only 38 percent of blacks and 30 percent of Latinos had the vaccination. While diabetes strikes 14 percent of the white population, the disease has higher rates among blacks and Latinos.

“It's a bigger issue for Region 9 (the Southwest region) because it has a higher Hispanic population than the rest of the country,” Flick said. “It's even more important for these populations to take advantage of the programs.”

source:www.mohavedailynews.com

Legionnaire's Disease investigated

The South Dakota Health Department says it has closed its investigation into a case of Legionnaire's Disease in Sioux Falls.

Officials say it's an isolated case, and they get reports of a half-dozen or so cases of Legionnaire's Disease each year.

More than a dozen people caught the disease in 2005 at Rapid City, and one of them died.

The fountain at a Mexican restaurant was determined to be the source of the problem.

Legionnaires' disease which is a form of pneumonia is caused by exposure to bacteria in a mist or vapor.

source:www.kxmb.com

Govt wakes up to pneumonia threat

India has, for the first time, decided to vaccinate children against haemophilus influenzae type B (HIB), the bacteria that causes illnesses like meningitis, pneumonia and septic arthritis.

Tamil Nadu will be the first state to vaccinate all new-born children with the HIB vaccine. A HIB immunisation programme will then be rolled out nationally. The decision comes after a $9 million HIB probe project to measure and document the burden of the bacteria found it to be present in abundance in the country.

Although India, with high mortality rates, had long known that pneumonia and meningitis were significant concerns, it assumed that HIB was not a major cause before this study was conducted.

Funded by GAVI and USAID, the probe was undertaken at the Christian Medical College, Vellore, Post-Graduate Institute of Medical Education and Research, Chandigarh, and the National Institute of Cholera and Enteric Diseases, Kolkata.

The project, spearheaded by the Indian Council of Medical Research, was part of a $37 million HIBS initiative recently launched jointly by Johns Hopkins Bloomberg School of Public Health, London School of Hygiene and Tropical Medicine, Centre for Disease Control and Prevention and WHO.

ICMR director general Dr N K Ganguly told TOI, “We have reviewed fresh evidence and have decided to use the HIB vaccine in India. We have asked GAVI to provide us funding worth $20 million to procure the vaccines which will first be used in Tamil Nadu and then on children across India. We will introduce the vaccine as soon as we get the grant from GAVI.”

Bangladesh, Pakistan and Nepal have also decided to introduce the vaccine. Ganguly’s announcement comes just a day after ‘The Paediatric Infectious Disease Journal’ published the findings of a large-scale study from Bangladesh on the effectiveness of the HIB vaccine.

The study, conducted by researchers from International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka Shishu Hospital and Johns Hopkins University showed that routinely vaccinating 60,000 children in Dhaka against HIB conjugate vaccine prevented over one-third of life-threatening pneumonia cases and approximately 90% of HIB meningitis cases.

“There has been disagreement about the total burden of HIB pneumonia and meningitis in Asia, but our findings provide evidence challenging the commonly held notion that these diseases are rare in Asia,” said Dr Abdullah Baqui of Johns Hopkins Bloom-berg School of Public Health, Baltimore.

source:timesofindia.indiatimes.com

Human Factor

Drug abuse causes hundreds of billions of dollars in economic losses and untold personal heartache. How to limit the damage? SALLY SATEL suggests we start by ditching the ‘brain disease’ model that’s popular with scientists and focus on treating addicts as people with the power to reshape their own lives. Despite its own prejudices, an HBO series transmits just this message of responsibility and optimism.
For nearly a century, the United States government has been waging one unsuccessful anti-drug crusade after another. Today, more than 20 million Americans abuse drugs and alcohol[1]. And while the users themselves pay a high price in stunted lives and heartache, the social and economic costs are staggering. The direct effects of addiction—homelessness, unemployment, and disease—and the costs of interdiction and incarceration are estimated at over $200 billion annually[2]. The annual burden in lost productivity in the workplace, mainly from absenteeism and accidents, is another $129 billion, and employees’ drug- and alcohol-related healthcare costs add $16 billion[3]. In all, that’s about 3 percent of our gross domestic product.

Addicts and their families—and the rest of us who help pick up the pieces—have it hard enough. The last thing we need is a confusing public health message about the nature of addiction. Yet that is exactly what was purveyed earlier in the year by an ambitious television series on HBO about substance abuse. While much of the series preached an ultra-medicalized philosophy of addiction—one I find woefully misleading—the broader message, paradoxically, was powerful and accurate: namely, that addicts are endowed with the ability to change their own lives.

Every so often a patient will ask me if I can 'hypnotize' him out of his habit.

Traditionally, efforts to cut drug abuse have been divided into two parts. Supply reduction tries to limit the availability of drugs. So far, despite enormous outlays of tax dollars and increased criminal penalties, results have been dismal. Meanwhile, demand reduction both tries to stop people from using drugs (prevention) and, if they start, tries to get them to stop (treatment). That’s where I come in. I am a psychiatrist in a methadone clinic in Northeast Washington, D.C.

My job is to help addicts quit heroin and not go back to it in the future. If this is a challenge for the clinician, it’s a monumental effort for the addict. Every so often a patient will ask me if I can “hypnotize” him out of his habit. One patient told me he wished there were an anti-addiction pill, “something to make me not want.” Indeed, that is the timeless quest of troubled addicts everywhere: not to want. It comes as no news to them, however, that recovery is very much a project of the heart and mind. Nor is it news that recovery is attainable.

This is why I chafe at the conventional scientific wisdom about addiction: namely, that it is “a chronic and relapsing brain disease.”[4] This view is much heralded by the National Institute on Drug Abuse, or NIDA, part of the National Institutes of Health. NIDA is funded at slightly over $1 billion a year and carries enormous authority on Capitol Hill, among grant-seeking scientists, and in medical schools. The “brain disease” idea is promoted at major rehab institutions such as the Betty Ford Center and Hazelden[5]; it is now a staple of anti-drug education in high schools and in counselor education. And, of course, lawyers play fast and loose with the brain disease rhetoric in courtrooms[6].

The brain disease concept sends a perilous public health message. First, it suggests that an addict’s condition is amenable to a medical cure (much as pneumonia is cleared with antibiotics). Second, it misappropriates language more properly used to describe conditions such as multiple sclerosis or schizophrenia—afflictions that are neither brought on by the sufferer himself nor modifiable by his desire to be well. Third, it carries a fatalistic theme, implying that users can never free themselves of their drug or alcohol problems.

The brain disease rhetoric also threatens to obscure the vast role of personal agency in perpetuating the cycle of use and relapse to drugs and alcohol. It sends a mixed message that undermines the rationale for therapies and policies that depend on recognizing the addict’s potential for self-governance.

Despite its worrisome implications, the scientists who forged the brain disease concept in the mid-1990s had good intentions. By placing addiction on equal footing with more conventional medical disorders, they sought to create an image of the addict as a hapless victim of his own wayward neurochemistry. They hoped this would inspire companies and politicians to allocate more funding for treatment. Also, by emphasizing dramatic scientific advances, such as brain imaging techniques, and applying them to addiction, they hoped researchers might reap more financial support for their work. Finally, promoting the idea of addiction as a brain disease would rehabilitate the addict’s public image from that of a criminal who deserves punishment into a sympathetic figure who deserves treatment.

Within clinical and research circles, the brain disease narrative quickly made a powerful impression. “The majority of the biomedical community now considers addiction, in its essence, to be a brain disease,”[7] says Alan Leshner, the former director of NIDA, who now heads the American Association for the Advancement of Science. To the public, however, the notion has largely been unknown.

Until now. This spring, the “chronic and relapsing brain disease” message got a big boost from HBO’s series called “Addiction,” which featured nine full-length segments plus a “supplementary series” that included interviews with medical experts and researchers about treatment and recovery. There was also a “complementary series” that comprised intimate portraits of the lives of four people, plus an impressive educational website and a book entitled Addiction: Why Can’t They Just Stop? Full-page ads with the tag line “Why can’t they just stop?” were placed in major newspapers and magazines.

My job is to help addicts quit heroin and not go back to it in the future. If this is a challenge for the clinician, it’s a monumental effort for the addict.

The series was produced in partnership with NIDA, the National Institute on Alcohol Abuse and Alcoholism, and the Robert Wood Johnson Foundation. Brain disease had center stage. As Nora Volkow, the neuroscientist who heads NIDA, explained in one episode, “Addiction is a disease of the brain that translates into abnormal behavior.”

But what exactly does that assertion mean? It’s no abstract question. The answer determines the extent to which we can and should hold addicts responsible for their actions—a matter which, in turn, determines to a significant degree our ability to reduce the effects of drug and alcohol abuse.

According to Volkow and other neuroscientists, “brain disease” refers to disruptions in the brain’s motivational and reward circuitry that result from the cumulative effect of repeated use of certain substances. As these neural pathways become “hijacked,” use that started as voluntary becomes less and less deliberate, harder and harder to control, and, in the most extreme cases, even automatic. The process unfolds through the action of a major neurotransmitter called dopamine, which, under normal circumstances, increases in the presence of any salient stimulus that is important or pleasurable, such as food, sex, or social bonding. It serves as a “learning signal.” An organism, animal or human, comes to desire, again and again, any experience that causes dopamine’s release.

When drugs, as opposed to food or sex, serve as the stimulus, the dopamine release is especially intense. Thus, each new infusion “teaches” the brain to desire drugs. Ultimately, the urge to use heroin or cocaine overrides a person’s interest in once-enjoyable activities—let alone the basic chores of living, which now seem drab by comparison. After a while, however, many addicts report getting very little pleasure from drinking or using drugs. So why does the intense desire to consume persist? According to Volkow and her colleagues, persistent exposure to drugs and alcohol damages the parts of the brain that evaluate experiences and plan appropriate actions.

Addicts’ brains, says Volkow, “have been modified by the drug in such a way that absence of the drug makes a signal to their brain that is equivalent to the signal of when you are starving…. [It is] as if the individual was in a state of deprivation, where taking the drug is indispensable for survival. It’s as powerful as that.”[8]

What’s so compelling about this model is that you can literally see it in action. Scientists use an imaging technique called positron emission tomography (PET) to produce a visual record of the brain on drugs. When a person is given a drug, or merely shown pictures of paraphernalia, a PET scan image will depict the brain’s reward centers glowing red with a rush of dopamine-related metabolic activity.

Such PET scans are prominently featured in the HBO series, and they seem convincing. Biology, however, is not destiny. In fact, the brain of an addict who is experiencing a drug craving but fights it off also lights up like a Christmas tree—as brightly as the brain of a person who planned to obtain drugs to quell the craving—because resistance activates additional inhibitory centers in the brain.

Nor can scans permit scientists to predict reliably whether a person with a desire-activated brain will act on that desire. Indeed, researchers have noted that self-reported craving does not necessarily correlate with a greater chance of actually using cocaine.[9] In other words, scans cannot distinguish between an impulse that is irresistible and an impulse that can be resisted but is not. “You can examine pictures of brains all day,” says philosopher Daniel Shapiro of West Virginia University, “but you’d never call anyone an addict unless he acted like one.”[10]

We tend to think of the cocaine addict in the throes of a days-long binge. He frantically gouges himself with needles, jams a new rock into his pipe every 15 minutes, or hungrily snorts lines of powder. Or we think of the heroin junkie either nodding off or doubled over in misery from withdrawal, so desperate for the next hit that he’ll get the money any way he can. In the grip of such forces, an addict cannot be expected blithely to get up and walk away. These tumultuous states—with neuronal function severely disrupted—are the closest drug use comes to being beyond the user’s restraint.

Yet addicts rarely spend all of their time in conditions of such intense neurochemical siege. In the days between binges, for example, cocaine addicts make many decisions that have nothing to do with drug-seeking. Should they clean the apartment? Try to find a different job? Kick that freeloading cousin off their couch for good? Heroin-dependent individuals often function quite well as long as they have regular access to some form of opiate drug in order to prevent withdrawal symptoms[11]. Most of my own patients even hold jobs while pursuing their heroin habits, which typically entail use about every six to eight hours.

In other words, there is room for other choices. These addicts could go to a Narcotics Anonymous meeting, for example, or enter treatment if they have private insurance, or register at a public clinic if they don’t. And yes, they could even stop cold turkey. I’ve interviewed scores of opiate addicts who have done it. They take lots of Valium-type drugs to handle withdrawal and suffer through a few days of vomiting, diarrhea, and cramping.

Imagine bribing an Alzheimer’s patient to keep her dementia from worsening, or threatening to impose a penalty on her if it did.

When Jamie Lee Curtis, who abused painkillers, appeared on a recent Larry King show that was devoted to addiction (and plugged the HBO series), guest host Maria Shriver asked her, “What made you get clean?” She responded, “Well, you know what, that turning point was a—was really a moment between me and God. I never went to treatment. I walked into the door of a 12-step program and I have not walked out since.” Apparently, Ms. Curtis never got the memo that addiction is a brain disease.

It is simply a fact that many people do stop spontaneously. It is also a fact that a lot of them will start up again weeks, months, or years later. But in the interim, they have command over whether or not they do.

The “chronic and relapsing” element of the brain disease narrative suggests that relapse is an inherent and virtually inevitable property of addiction. Volkow sums it up: “Just as an asthma attack can be triggered by smoke, or a person with diabetes can have a reaction if they eat too much sugar, a drug addict can be triggered to return to drug abuse.” Scientists also explain the process in neurobiological terms. During the early phase of recovery, the brain’s dopamine stores are still somewhat depleted from the recent period of heavy use, leading to feelings of apathy and “grayness,” a state that can be temporarily reversed with more drugs.

What’s more, according to this theory, the brain’s dopamine-rich centers, even if they are less stoked than normal, remain hypersensitive, so that an encounter with an old drug buddy, say, or a whiff of whisky can provoke sharp craving, as Pavlov could have predicted.
Nonetheless, according to neuroscientist Steven Hyman, professor of neurobiology at Harvard Medical School, addicted individuals are not reduced to “zombies who are permanently controlled by external cues. As overvalued as drugs become, as potent as the effects of drug cues on behavior, other goals are not extirpated.”[12]

An important therapy for reducing the intensity of craving in newly abstinent patients is called “relapse prevention,” a form of cognitive-behavioral therapy, a well-established and effective treatment for depression and other conditions. Patients are helped to identify cues that reliably trigger a burst of desire to use the drug. These cues are generally the “people, places, and things” that the addict associates with drug use, but some of the triggers are curiously idiosyncratic. For example, a teacher trying to recover from cocaine addiction might begin to think lovingly about cocaine, even tasting it in the back of his throat, when he sees the powdered residue of classroom chalk[13].

Internal cues, such as stress and boredom, can be powerful too. Patients rehearse strategies for avoiding the cues if they possibly can, and managing the craving when they cannot. They learn to observe themselves when they have an urge to use so they can buy enough time to talk themselves out of acting.

Perhaps one day we’ll develop a medication to blunt craving—and I’m sure I would prescribe it—but the fact is that even intense urges need not be obeyed. And as a person begins to develop other sources of pleasure and interest, these will generate their own outpouring of dopamine, to put it in brain-speak. But an addict won’t replace substances with more compelling preoccupations without a reason; something has to be at stake. Sometimes it’s a threat that gets his attention—the risk of jail, of losing a job, a family, or a reputation. Sometimes it’s the challenge of facing who he has become.

Lisa’s cell phone rings about every ten minutes, and she flirts with the prospective johns. Then it is time to use. “Wanna see me get high?” she asks the filmmaker.

Author Jacob Sullum has interviewed many drug users who became aware that they were sliding down the path to full-blown addiction—and pulled themselves back. “It undermined their sense of themselves as individuals in control of their own destinies. And so they stopped,” Sullum writes. “That doesn’t mean that giving up cocaine might not be harder for different people in different circumstances, but it does show that the chemical does not neutralize free will.”[14]

Even among those who have not pulled themselves back from the brink, there is a broad range of behavior. Yes, some have held up gas stations to get money, but others have never stolen a cent. In fact, the shock of almost becoming a criminal, of stealing from a family member, or of sleeping through an infant’s screams of pain was just what brought them in to our clinic. “My God, I almost robbed my own sister,” one exclaimed in self-disgust. “What kind of mother am I?” asked another, incredulous at her dereliction.

During the most intense and troubled phase of their use, these patients had a spasm of self-reproach and a sudden flash of self-awareness that moved them to do something to fix their problem. It is epiphanies like these that make me wonder about the matter-of-fact pronouncement of several of the HBO experts that, in addiction, “the judgment part of the brain becomes completely nonfunctional.” Granted, not every addict has an “aha!” moment—many are arm-twisted into our clinic by spouses, children, or the courts. But for those who do, it would be fascinating to know what their brain scans looked like at the time of revelation. Probably just as afire as those of addicts using cocaine.

Indeed, for those in recovery at any phase, the path back to use is well marked by scores of red flags—small, deliberate choices, made many times a day: with whom to spend time, which neighborhoods to visit, whether to allow oneself to become bored. With each choice, the addict makes himself more vulnerable to continued use. These small decisions, then, are critical to relapse.

The process also indicates why we should not hesitate to hold actor Mel Gibson responsible for his alcohol-soaked anti-Semitic rant last year. And why Representative Patrick Kennedy was suffering from far more than a “brain disease” when he crashed his car on Capitol Hill last year. After all, a remorseful substance abuser almost always has substantial knowledge of how he behaves when under the influence, yet, in spite of this insight, sets anew the stage on which history will repeat itself.

Yes, it is true than an addict is not responsible for his inborn vulnerabilities, but once he knows he has them—a point made vividly clear by having lived firsthand through one or more harrowing episodes of reckless use—he is fully responsible for his actions.

What’s so compelling about this model is that you can literally see it in action in a PET scan.

“If the brain is the core of the problem,” wrote former NIDA head Alan Leshner, “attending to the brain needs to be the core of the solution.” In a seminal 1997 article in the journal Science entitled “Addiction Is a Brain Disease, and It Matters,” Leshner goes on to explain how: by using “medications or behavioral treatments to reverse or compensate for brain changes.”[15]

Fortunately, I have never met a flesh-and-blood clinician who talks this way. Nor, apparently, has HBO. For all the brain scans and the focus on brain disease, the series presented savvy clinicians giving edifying tutorials on treatments—therapies aimed first and foremost at the person, not his physical organ. A poignant array of stories showed why it makes more sense to address the human factor than to set out to change the brain’s chemistry.

Consider the HBO episode on a drug court in South Boston. Drug courts are jail-diversion programs that offer intensive, supervised substance-abuse treatment to addicts who have committed nonviolent, drug-related crimes. Eligible offenders who choose drug court over routine court processing are closely monitored by a judge for roughly a year. If they fail a drug test or violate some other expectation, the judge administers swift and reliable sanctions, such as community service or a night in jail. Subsequent violations elicit more severe punishments, culminating in incarceration if the offender continues to flout the rules. The judge also rewards good behavior. A participant who does well for several months progresses to a new phase of treatment with less intense oversight.

Most patient-offenders respond well to this graduated behavioral approach. Swift response to infractions drives home the message that one’s own actions are taken seriously—that the addict controls his fate. Dropout rates are significantly lower than in standard treatment, and criminal recidivism is reduced compared with standard court processing with probation[16]. Contrary to conventional psychiatric wisdom, addicts don’t have to want to change their lives for a treatment program to succeed. Gradually, they absorb the values of the program as they appreciate the benefits of drug-free living[17].

With the prospect of doing time hanging over his head, an offender is more likely to finish treatment. Leverage is crucial. “Drug court uses the power of the judge to get people to change their way of life,” said the judge in the HBO documentary, Robert P. Ziemian. “The fact that [participants] have coercion keeps them facing their problems” in treatment. In short, the judge holds the person, not his brain, accountable for setbacks and progress.

Volumes of data attest to the fact that the longer addicts stay in treatment, the better their chances of turning their lives around. Holding people accountable for resuming use is not “blaming the victim,” as the brain disease model implies. To the contrary, acknowledging their responsibility expresses faith in a human capacity for restraint and self-determination—a much more optimistic and realistic message than “young man, you have a chronic and relapsing brain disease.”

In the days between binges, for example, cocaine addicts make many decisions that have nothing to do with drug-seeking. Should they clean the apartment? Try to find a different job? Kick that freeloading cousin off their couch for good?

By combining the moral and medical approaches to treatment—which work better together than either does alone—drug courts have proven an effective innovation. At the heart of drug courts (and there are now over 1,600 around the country) is a well-established practice called contingency management[18]. A broad scientific literature shows that rewards and sanctions for behavior typically exert a dramatic effect on a person’s drug use[19]. By contrast, no amount of reinforcement or punishment can alter the course of a truly autonomous biological condition. Imagine bribing an Alzheimer’s patient to keep her dementia from worsening, or threatening to impose a penalty on her if it did[20].

Another valuable intervention is self-help. An episode about Steamfitters Local Union 638 in Astoria, Queens, featured an employee-assistance program headed by a charismatic steamfitter, a recovering alcoholic who drove home the point that “we use brotherhood as a way of intervening.” Borrowing from AA , the union program provided round-the-clock social support and a community of peers, some of whom have been sober for many years.

Unfortunately, the HBO series barely mentioned Alcoholics Anonymous itself, the most widely used and successful method for staying sober. “Well-done studies repeatedly find that AA is more effective in moving people to abstinence than any other form of outpatient treatment for alcoholism,” says Keith Humphreys, professor of psychiatry at Stanford University and an expert in the field. “On additional measures, like reduced days missed at work, improvement in depression, and better family life, AA is comparable to other treatment. And, what’s more, the price is right: it’s free.”[21]

The omission by HBO, however, was not altogether surprising. After all, the AA fellowship extols the idea that the alcoholic must enter into nothing less than a crucible of character change—must become more humble, honest, and morally reflective by working through the program’s 12 steps. This is not a philosophy that meshes well with the biological version of addiction.

One of the most riveting HBO episodes was a full-length profile of Lisa, a 37-year-old woman living in a run-down hotel room in Toronto and working as a call girl. For most of the show, we see her sitting on the bed talking to the filmmaker behind the camera. She is animated, engaging, and witty. Flipping her shiny brown hair and inspecting her well-kept nails, she talks eagerly about how much she makes selling sex, how much she spends on drugs, and what cocaine feels like (“someone coming up behind you and hugging you…warm”).

Lisa’s cell phone rings about every ten minutes, and she flirts with the prospective johns. Then it is time to use. “Wanna see me get high?” she asks the filmmaker. She injects cocaine in a very deliberate manner, and when she hits a dud vein in her arm, which happens four times, she moves on to another one unfazed.

Lisa has been through many rehabs, we are told. When she was filmed, she was healthy and engaging; in other words, she looked and talked like someone who was recently abstinent but is back in the early stages of her next downward spiral. She has no interest in stopping things at this point. “Right now, I am in no position to go into recovery. [This way of life] is working for me…. I have money, drugs, business. I’m O.K.”

To say Lisa’s problem is the effect of cocaine on her brain is to miss the true threat to her well-being: Lisa herself. “I always use for a reason. It’s repressing what needs to be repressed,” she says. She yearns for “oblivion” through drugs and calls her use “complete selfishness.”

Lisa’s saga is a stunning illustration of the shortcomings of the medicalized view of addiction, which is silent on the fact that many people are drawn to drugs in the first place because the substances temporarily help quell all manner of pain they endured before ever becoming addicted: persistent self-loathing, anxiety, alienation, deep-seated intolerance of stress or boredom, pervasive loneliness. When Lisa says she seeks “oblivion,” I am reminded of screenwriter Jerry Stahl and his potent memoir of addiction, Permanent Midnight: “The point is, everything, good or bad, boils back to the decade on the needle, and the years before that imbibing everything from cocaine to Romilar, pot to percs, LSD to liquid meth and a pharmacy in between: a lifetime spent altering the single niggling fact that to be alive means being conscious.”[22]

Cocaine, heroin, or alcohol may provide relief, but it is temporary, and when the addict finally does stop, the raw vulnerabilities that prompted his devotion to drugs in the first place are still there, throbbing like a fresh surgical incision as the painkillers wear off.

High-quality long-term rehabilitation takes the personal dimension of drug abuse seriously. Phoenix House, a nonprofit institution based in New York, is the national leader in this approach, and HBO featured one of its rehab programs for adolescents. Phoenix Academy in Austin, Texas, provides up to 24 months of residential care with the underlying philosophy that the addict himself, not his drug or his brain, is the primary problem. Addiction is understood more as a symptom than a disease. The root pathology is the patient’s failure to engage in purposeful activity and achievement, and to acquire a feeling of self-worth and a capacity for self-control. On top of this, a young person’s heavy drug use derails him from completing the maturational tasks of adolescence. By age 18, he is lost when it comes to consolidating a personal identity, forming a concept of his future, or figuring out how to give his life meaning.

“Drugs cover up all your problems,” says Ted, a teenager forced by his parents to attend the academy. “Here there are no drugs, so you are forced to deal with your problems. [It] makes you internalize wanting to have a schedule and needing to stay busy all the time.”

All residents must work, get an education, or learn a skill. When patients are deterred from acting on every impulse, they can learn the basic psychological skills so many of us take for granted: how to delay gratification, develop relationships based on trust, devise internal strategies for coping, and accumulate the small successes that eventually coalesce into a sense of self-worth. They learn to live in cooperation with others and to accept authority and supervision—concepts essential to workplace success.


Perhaps one day technology will change the situation, and talking about addiction in the language of neurobiology will be more useful. But for now, the clinician must engage a patient in a consideration of himself.

By the time I had finished watching episodes like the one on Phoenix Academy, I realized that the series had actually made most of the points I would want the public to know about addiction, potential treatments, and the dynamics of recovery. It showed the profound truth about drug abuse: that individuals have the power to shape their own lives. It was a notable conclusion that all of the featured scientists supported as well—even though the brain disease rhetoric would imply otherwise. To be sure, PET scans and tutorials on neurobiology have a part in any comprehensive examination of addiction but, in the end, it was hard to imagine that viewers could come away thinking that the addict’s disembodied brain held the secrets to understanding or helping him. The human face of the series could not help but dispel such a narrow impression.
I am a clinician. I treat real-life patients. As a pragmatist, I can’t see the advantage of conceptualizing addiction as a “chronic and relapsing brain disease.” At the same time, no reasonable person would disagree that addiction is mediated through the dopamine system of the brain. Or that intense activation of the dopamine system makes it more difficult for users to quit. Or that genetic factors influence the intensity of the effect that users derive from substances, the rapidity with which they develop compulsive use, the potency of their cue-related craving, and the severity of withdrawal symptoms.

Nevertheless, I remain loyal to the more traditional understanding of the word “addiction,” the one that I assume the general public holds: namely, that addiction is a condition in which people engage in damaging and compulsive use of mind-altering substances. To me, that definition casts behavior as the essence of the problem; it also stipulates that addicts themselves have the ability to change that behavior.

I prefer the language of self-agency because it is the one that translates best into efforts to prevent, treat, and overcome addiction. Perhaps one day discoveries unearthed by brain science will oblige me to reconsider, and talking about addiction in the idiom of neurobiology will be more fruitful in the clinical domain. But for now, people like me must engage a patient in a consideration of himself—his anxieties and aspirations—not his brain.

source:www.american.com

New Way To Target And Kill Antibiotic-resistant Bacteria Found

Putting bacteria on birth control could stop the spread of drug-resistant microbes, and researchers at the University of North Carolina at Chapel Hill have found a way to do just that.
"Antibiotic resistance propagates in bacteria by moving DNA strands containing the resistance genes to neighboring cells. An enzyme called relaxase is essential for this process. Bisphosphonates, already approved to treat bone loss, have now been shown to potently disrupt the relaxase function. Some bisphosphonates prevent the transfer of antibiotic resistance genes and selectively kill bacterial cells that harbor resistance. (Credit: Scott Lujan, University of North Carolina at Chapel Hill)"
The team discovered a key weakness in the enzyme that helps "fertile" bacteria swap genes for drug resistance. Drugs called bisphosphonates, widely prescribed for bone loss, block this enzyme and prevent bacteria from spreading antibiotic resistance genes, the research shows. Interfering with the enzyme has the added effect of annihilating antibiotic-resistant bacteria in laboratory cultures. Animal studies of the drugs are now underway.

"Our discoveries may lead to the ability to selectively kill antibiotic-resistant bacteria in patients, and to halt the spread of resistance in clinical settings," said Matt Redinbo, Ph.D., senior study author and professor of chemistry, biochemistry and biophysics at UNC-Chapel Hill.

The study provides a new weapon in the battle against antibiotic-resistant bacteria, which represent a serious public health problem. In the last decade, almost every type of bacteria has become more resistant to antibiotic treatment. These bugs cause deadly infections that are difficult to treat and expensive to cure.

Every time someone takes an antibiotic, the drug kills the weakest bacteria in the bloodstream. Any bug that has a protective mutation against the antibiotic survives. These drug-resistant microbes quickly accumulate useful mutations and share them with other bacteria through conjugation -- the microbe equivalent of mating.

Conjugation starts when two bacteria smoosh their membranes together. After each opens a hole in their membrane, one squirts a single strand of DNA to the other. Then the two go on their merry way, one with new genes for traits such as drug resistance. Many highly-drug resistant bacteria rely on an enzyme, called DNA relaxase, to obtain and pass on their resistance genes. A mutation that provides antibiotic resistance can sweep through a colony as quickly as the latest YouTube hit.

The researchers analyzed relaxase because it plays a crucial role in conjugation. The enzyme starts and stops the movement of DNA between bacteria. "Relaxase is the gatekeeper, and it is also the Achilles' heel of the resistance process," Redinbo said.

Led by graduate student Scott Lujan, the team suspected they could block relaxase by searching for vulnerability in a three-dimensional picture of the relaxase protein. Lujan, a biochemistry graduate student in the School of Medicine, confirmed the hunch using x-ray crystallography, which creates nanoscale structural images of the enzyme.

The researchers predicted that the enzyme's weak link is the spot where it handles DNA. Relaxase must juggle two phosphate-rich DNA strands at the same time. The team suspected a chemical decoy -- a phosphate ion -- could plug this dual DNA binding site. Redinbo, who has a background in cancer and other disease-related research, realized that bisphosphonates were the right-size decoy.

There are several bisphosphonates on the market; two proved effective. The drugs, called clodronate and etidronate, steal the DNA binding site, preventing relaxase from handling DNA. This wreaks havoc inside E. coli bacteria that are preparing to transfer their genes, the researchers found. Exactly how bisphosphonates destroy each bacterium is still unknown, Redinbo said, but the drugs are potent, wiping out any E. coli carrying relaxase. "That it killed bacteria was a surprise," he said. By targeting these bacteria, the drugs act like birth control and prevent antibiotic resistance from spreading.

Redinbo, who cautions that the results only apply to E. coli, said further testing will reveal whether bisphosphonates also attack similar species like Acinetobacter baumannii (hospital-acquired pneumonia), Staphylococcus aureus (staph infections) and Burkholderia (lung infections).

"We hope this discovery will help existing antibiotics or offer a new treatment for antibiotic-resistant bacteria," he said.

The drugs may be most effective at sites where clinicians can best control dosage -- on skin and in the gastrointestinal tract, Redinbo said. Other applications may include disinfectants and treatments for farm animals.

Study coauthors, all from UNC-Chapel Hill, include Laura Guogas, Heather Ragonese and Steven Matson. Redinbo is a member of the UNC Lineberger Comprehensive Cancer Center.

Redinbo and his colleagues have filed a patent and formed a small company to further develop the technology.

The study appears online the week of July 9, 2007, in the Proceedings of the National Academy of Sciences. Funding was provided by the National Institutes of Health.

Note: This story has been adapted from a news release issued by University of North Carolina at Chapel Hill.

source:www.sciencedaily.com

Three Children in Western Australia Die Within 24 Hours Of Falling Ill

Three children, died in Perth within 24 hours of falling ill. The West Australian Health Department says the children died from contracting a combination of a flu strain and a pneumonia-causing bacterial infection.

The department's Communicable Disease Control director Dr Paul Van Buynder said all three children were under the age of five.

Dr Van Buynder said, "It's apparent that all three of the children who had tragic consequences had very similar illnesses that started with a mild Influenza A infection and gone on from there to develop secondary bacterial complications."

"Most of the children who have a secondary bacterial infection will develop a full-blown pneumonia and that will be part of the cause of the tragic consequences."

Worried parents in West Australia have inundated emergency departments after the health authorities issued a warning on Friday urging parents to get children with fever and lethargy checked.

Tasmania's Public Health Director Roscoe Taylor said parents needed to be vigilant with their children.

Dr Taylor said, "The situation with influenza is the same no matter which part of Australia it's affecting."

"Influenza A can be very serious in the young and elderly. It can cause major complications, from pneumonia through to other problems, including death."

Dr Taylor said there had been at least half a dozen cases of influenza A confirmed in Tasmania in the past three weeks.

He said, "And that will only be the tip of the iceberg because only a small percentage of people with the disease get laboratory tested to confirm it."

As well as vaccination, Dr Taylor encouraged people to:

- Stay at home if sick.

- Keep sick children at home.

- Cover sneezes and coughs.

- Wash hands regularly.

Meanwhile, Queensland Health is urging all parents to vaccinate their young children against flu, especially if they also suffered from a medical condition such as heart disease or diabetes.

Health officials in Victoria said the number of flu cases were below average so far, while in NSW an initial increase in the number of flu cases had been reported going into the season.


source:www.allheadlinenews.com

Beware of bacteria, fungi lurking in soil

Although working with soil is rarely considered a health risk to gardeners and outdoor workers, some diseases are transmitted through soil. Inhaling diseased spores or becoming exposed to bacterial diseases in the soil by dirt entering a cut or scratch are common methods of infection.

Avoid using raw manure, and when working on dusty or previously uncultivated sites, wet down the soil to reduce dust in the air.

Wearing gauntlet-style work gloves, long sleeves, long pants and sturdy shoes can reduce the risk of infection.

Diseases that can spread to humans through soil include:

• Tetanus. Sometimes called "lockjaw," tetanus, a disease that affects the central nervous system, is caused by a species of the Clostridia bacteria that occurs naturally in soil. Tetanus can be easily prevented through regular vaccinations - it is much easier to prevent than to cure. While most children receive tetanus vaccinations as part of their immunizations, many adults become susceptible by failing to get tetanus booster shots.

• Histoplasmosis. A fungal disease that enters through the lungs via airborne soil particles infected with fungal mold, histoplasmosis is also called Ohio River Valley Fever and the "Pigeon Poop" disease. Although prevalent in the Ohio River Valley and the Mississippi River Valley, it is also common across the central U.S., the middle Atlantic region and the southeast. The fungus tends to be more prevalent in soils containing bird or bat droppings. The disease is found most often in places where the droppings are several years old.

Those with AIDS or other immune disorders may be particularly susceptible to this disease, as are people with pneumonia, emphysema or chronic bronchitis. Symptoms are flulike and may be combined with pneumonia or may cause symptoms similar to pneumonia. Histoplasmosis may also be asymptomatic.

source:www.dailyherald.com

Leaflets highlight dangers disease

CATTLE and sheep diseases cost money to the whole food supply chain and one of HCC’s central industry development aims is to assist farmers in improving the health of their animals.

HCC has created a series of nine, up-to-date and informative leaflets highlighting herd and flock health planning.

They are published to coincide with the Royal Welsh Show, and all come with a simple sheet for farmers to record any of the health issues that have occurred on their farms, any action they plan in response to the diseases and any other decisions that need to be made to eradicate or improve the disease in the herd and flock.

The set of nine health leaflets put the spotlight on abortion, clostridial disease, IBR, joint Ill, lameness, leptospirosis, pneumonia, scouring and watery mouth and vaccination.

Most of these illnesses, diseases or conditions can be expensive and serious for the farmer – for instance, even a five per cent abortion rate can reduce potential gross margin by 10%. And in the case of pneumonia, even a 2% mortality rate can reduce potential gross margin by 10%.


Story continues Continue story
ADVERTISEMENT

These are just two of the profit-damaging conditions that can erode prices – and the leaflets look at seven other hazards.

Leptospirosis, the main cause of disease in cattle in Wales, is an infectious and contagious bacterial disease; Clostridia is a group of spore-forming organisms found in the soil which can cause a series of serious and even fatal diseases.

Vaccination is important to successful flock management, but incorrect or careless injection techniques produce abscesses that have to be cut away in the slaughterhouse causing financial losses to the producer – losses that are hard to assess because most never see the carcass mutilation that is necessary to remove vaccination abscesses from high-priced areas.

A few countries are now close to eradication of infectious bovine rhinotracheitis and herds may soon have to prove that they are free from IBR in order to gain access to export markets.

If you would like find out more about this series, contact HCC on 01970 625050.

Gwyn Howells is chief executive of the Welsh meat promotion authority Hybu Cig Cymru

source:icwales.icnetwork.co.uk

Man dies of legionnaire's disease in southern Spain

Malaga, Spain - A 68-year-old man has died of legionnaire's disease in the southern Spanish tourist resort of Benalmadena, health officials said Monday. Fourteen more people were reported infected.

The bacteria causing the outbreak were believed to have spread from a cooling tower pertaining to an ice skating rink. The responsibility of the companies managing it was being investigated.

Legionnaire's disease is a type of pneumonia. Symptoms include fever, chills, a cough, muscle aches and headaches.

source:www.earthtimes.org

Govt invites business to help prevent diarrhea

The Health Ministry and the private sector are working together to promote hand washing to help tackle the staggering number of deaths from diarrhea in the country, particularly among children.

Diarrhea has become one of the most common diseases in Indonesia, killing more than 100,000 children every year.

According to the Jakarta Health Agency, Jakarta saw more than 20,000 people suffer from diarrhea in 2006. More than 11,000 diarrhea cases have been recorded from January to July this year.

"Washing hands with soap in the proper way can help people avoid getting diarrhea," Tjandra Yoga Aditama, the director of Communicable Disease Control at the ministry, told the Open Partnership Meeting on Monday.

The meeting, held by the ministry, the National Development Planning Board and other state institutions concerned with sanitation and public facilities, was also aimed at encouraging the non-government sector to participate in a hand washing campaign through the Public-Private Partnership Program.

Tjandra said Jakartans and people living in other cities had low awareness of proper hand washing.

"Many people only wash their hands when they feel they're dirty."

"People should wash their hands in running water before having something to eat, before preparing food, when they hold babies (and) after defecating and urinating," he said.

Tjandra said poor sanitation and unhealthy lifestyles had contributed to the high number of diarrhea patients in Indonesia, with 423 out of 1,000 people suffering from the disease. In many areas, the disease was so frequent as to be classified as an "extraordinary occurrence".

"Children are the most prone to this disease," he said.

Acute diarrhea is usually caused by infection and may be accompanied by bloating, nausea and abdominal pain, sometimes leading to death.

"The entrance of these germs into the human body affects the alimentary canal and the respiratory system the most," he said, adding that habitual hand washing could also help people avoid respiratory diseases such as bird flu and pneumonia.

According to Wan Alkadri, a director at the Health Ministry, hand washing prevented the transmission of the dangerous pathogens that caused diarrhea.

"Habitual hand washing is considered to a be do-it-yourself vaccine, which is more effective than any other vaccine," he said.

Since 2005, 90 out of a total of 111 bird flu patients have died, the majority of the deaths occurring in West Java.

The government needed the private sectors' participation to get the best results from the promotion campaign, Wan said.

"In its implementation, this program needs the private sectors' involvement. Their involvement would allow us to extend our capabilities and make the program sustainable," he said.

source:www.thejakartapost.com

Legionnaire’s disease claims life

A BRITISH national has become the first mortal victim after an outbreak of legionnaire’s disease at an ice rink in Benalmadena.

The 68-year-old, whose name was given as James Peter Olsen, was taken to hospital in nearby Malaga on July 2 after complaining of pneumonia-like symptoms. He died eight days later.

A total of 13 people are reported to be in local hospitals receiving treatment following the detection of the virus in the cooling system of the Club de Hielo in the popular Costa del Sol resort.

source:www.theolivepress.es

Labels